Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Zeyzelf Twice weekly 4.6 mg/24 h transdermal patch

Active Ingredient:
rivastigmine
Company:  
Luye Pharma Limited See contact details
ATC code: 
N06DA03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Rivastigmine patch (Zeyzelf) - Instructions for use and patient diary - for patients

Instructions for use and a patient diary including medication record sheets for patients that have been prescribed Zeyzelf Patch (rivastigmine transdermal system) to ensure the correct use of the patch.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Luye Pharma Limited
Company image
Address
Surrey Technology Centre, 40 Occam Road, Surrey Research Park, Guildford, GU2 7YG
Medical Information e-mail
[email protected]